Tri-iodothyronine (T<sub>3</sub>)
| Tri-iodothyronine (T3) | | | |
| Number | | 002188 |
| CPT | | 84480 |
| Related Information | | Thyroid Profile Thyroid-Stimulating Hormone (TSH) |
| Synonyms | | T3 ; T3 Hormone ; T3, Total ; Total T3 |
| Specimen | | Serum |
| Volume | | 1 mL |
| Minimum Volume | | 0.3 mL (Note: This volume does not allow for repeat testing.) |
| Container | | Red-top tube or gel-barrier tube |
| Collection | | If a red-top tube is used, transfer separated serum to a plastic transport tube. |
| Storage Instructions | | Refrigerate |
| Causes for Rejection | | Plasma specimen |
| Reference Interval | | See table.1
| Age | Male
(ng/dL) | Female
(ng/dL) | | 0-1 mo | 15-210 | 15-200 | | 2-11 mo | 95-275 | 50-264 | | 1-5 y | 80-253 | 126-258 | | 6-10 y | 96-232 | 104-227 | | 11-15 y | 73-199 | 96-211 | | 16-18 y | 69-201 | 91-164 | | >18 y | 85-205 | 85-205 |
|
| Use | | Thyroid function which is particularly useful in the diagnosis of T3 thyrotoxicosis, in which T3 is increased and T4 is within normal limits. T3 toxicosis is occasionally found in Graves' disease. It occurs with a single toxic nodule, multinodular thyrotoxicosis, and following treatment with T3 (Cytomel®).2 It is increased in and occasionally helpful for confirmation of diagnosis of conventional hyperthyroidism, in which commonly both T3 and T4 levels are increased. T3 is needed in patients with clinical evidence for hyperthyroidism, in whom the usual thyroid profile is normal or borderline. Reported to be normal to slightly increased with familial dysalbuminemic hyperthyroxinemia. Recommended for patients with supraventricular tachycardia, for patients with fatigue and weight loss not otherwise explained, or for those with proximal myopathy and in whom T4 levels are not elevated.3 |
| Limitations | | T3 is decreased with nonthyroidal chronic diseases and influenced by the state of nutrition. It is not helpful for evaluation of hypothyroidism. It may be normal with thyrotoxicosis (thyroxine thyrotoxicosis).4 Variations in TBG and other binding proteins can affect T3. Such increases may be found with use of oral contraceptives, pregnancy, and other binding protein abnormalities. Fasting causes T3 and TSH to decrease.5 |
| Methodology | | Immunochemiluminometric assay (ICMA) |
| Additional Information | | Increased T3 often occurs in hyperthyroidism, but in approximately 5% of cases only T3 is elevated, “T3 toxicosis.” Do not confuse T3 with T3 uptake; these are two different tests. The latter is done very commonly as part of the usual thyroid profile. Less than 1% of T3 is unbound. |
| Footnotes | | - Soldin SJ, Morales A, Albalos F, et al, “Pediatric Reference Ranges on the Abbott IMx for FSH, LH, Prolactin, TSH, T4, T3, Free T4, Free T3, T-Uptake, IgE, and Ferritin,” Clin Biochem, 1995, 28(6):603-6.
- Bethune JE, “Interpretation of Thyroid Function Tests,” Dis Mon, 1989, 35(8):541-95.
- Morley JE, Slag MF, Elson MK, et al, “The Interpretation of Thyroid Function Tests in Hospitalized Patients,” JAMA, 1983, 249(17):2377-9.
- Blank MS and Tucci JR, “A Case of Thyroxine Thyrotoxicosis,” Arch Intern Med, 1987, 147(5):863-4.
- Unger J, “Fasting Induces a Decrease in Serum Thyroglobulin in Normal Subjects,” J Clin Endocrinol Metab, 1988, 67(6):1309-11
|
| References | | Greenspan FS and Rapoport B, “Thyroid Gland,” Basic and Clinical Endocrinology, Greenspan FS and Forsham PH, eds, Los Altos, CA: Lange Medical Publications, 1983, 153. Ingbar SH, “Diseases of the Thyroid,” Harrison's Principles of Internal Medicine, 11th ed, Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds, New York, NY: McGraw-Hill, 1987, 1732-52. Takamatsu J, Kuma K, and Mozai T, “Serum Tri-iodothyronine to Thyroxine Ratio: A Newly Recognized Predictor of the Outcome of Hyperthyroidism Due to Graves' Disease,” J Clin Endocrinol Metab, 1986, 62(5):980-3. Watts NB and Keffer JH, Practical Endocrine Diagnosis, 4th ed, Philadelphia, PA: Lea & Febiger, 1989. |
|